These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32582726)

  • 21. The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer.
    Shi M; Zhang H; Yao G; Wu J; Zhu C; Zhang X; Ren Y
    Front Oncol; 2020; 10():586603. PubMed ID: 33154948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Circumferential Resection Margin Is a Prognostic Predictor in Colon Cancer.
    Tang XY; Huang MX; Han SQ; Chang Y; Li ZP; Kao XM; Chen YY; Liu C; Huang YD; Chen YT; Lei ZJ; Chu XY
    Front Oncol; 2020; 10():927. PubMed ID: 32670875
    [No Abstract]   [Full Text] [Related]  

  • 26. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study.
    Wang G; Li Q; Chen W
    BMC Cancer; 2021 Jul; 21(1):778. PubMed ID: 34225672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
    Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
    Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
    Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
    Int J Colorectal Dis; 2019 Apr; 34(4):629-639. PubMed ID: 30661101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
    Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
    J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer.
    Liu Q; Luo D; An H; Zhang S; Cai S; Li Q; Li X
    J Cancer; 2019; 10(5):1209-1215. PubMed ID: 30854130
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base.
    Mukkamalla SKR; Huynh DV; Somasundar PS; Rathore R
    Front Oncol; 2020; 10():568417. PubMed ID: 33042845
    [No Abstract]   [Full Text] [Related]  

  • 33. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
    Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
    Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer.
    Li H; Fu G; Wei W; Huang Y; Wang Z; Liang T; Tian S; Chen H; Zhang W
    Front Oncol; 2020; 10():595107. PubMed ID: 33312954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy for stage II colon cancer: who really needs it.
    Yang Y; Yang Y; Yang H; Wang F; Wang H; Chen Q; Liu Y; Li A; Zhang Q
    Cancer Manag Res; 2018; 10():2509-2520. PubMed ID: 30123000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.
    Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA
    Gynecol Oncol; 2019 Aug; 154(2):302-307. PubMed ID: 31155308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
    Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
    Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.